Novozymes Reports Strong 2008 Results
Bagsvaerd, Denmark (ots/PRNewswire) - Leading biotechnology company Novozymes reports 13% sales growth in 2008. Earnings were also very satisfactory. Growth outlook for 2009 of 8-13% in DKK in an uncertain market. Strong long-term trends lead to new, increased targets and higher investments to support higher future growth level. - 2008 sales up by 13% in local currencies (LCY), 10% in DKK, ending at DKK ...
mehr